Interestingly, although the role played by MYC/PGC-1α axis is controversial [38], several reports have demonstrated that PGC1-α is involved in chemoresistance [39] and the inhibition of the PGC-1α pathway has been found to activate glycolysis [40] and to sensitize melanoma to oxidative damage [41]. Here, PPARGC1A is linked to melanoma.